Barclays’s SEQUENOM INC NEW SQNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,035,500
Closed -$1.04M 6725
2015
Q4
$1.04M Buy
1,035,500
+509,000
+97% +$871K ﹤0.01% 2585
2015
Q3
$527K Buy
526,500
+511,500
+3,410% +$1.25M ﹤0.01% 3305
2015
Q2
$45K Sell
15,000
-7,000
-32% -$26.3K ﹤0.01% 5226
2015
Q1
$66K Sell
22,000
-42,800
-66% -$157K ﹤0.01% 5129
2014
Q4
$194K Sell
64,800
-12,300
-16% -$39.8K ﹤0.01% 4664
2014
Q3
$154K Sell
77,100
-500
-0.6% -$1.83K ﹤0.01% 4967
2014
Q2
$233K Buy
77,600
+27,300
+54% +$79.9K ﹤0.01% 4679
2014
Q1
$101K Sell
50,300
-85,000
-63% -$203K ﹤0.01% 5448
2013
Q4
$270K Buy
135,300
+1,700
+1% +$4.03K ﹤0.01% 4707
2013
Q3
$267K Buy
133,600
+44,400
+50% +$149K ﹤0.01% 4763
2013
Q2
$376K Buy
+89,200
New +$357K ﹤0.01% 4544

Barclays's SQNM Position: Q3 2016 in Review

Barclays sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 14,349 shares — an estimated $13K sold.

Barclays first reported a position in SQNM in Q2 2013 and held it in 13 quarters. The position peaked at $352K in Q3 2014. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.

  • Barclays reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
  • Barclays sold 14,349 SEQUENOM INC NEW shares in Q3 2016, an estimated $13K.
  • Barclays first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 13 quarters.
  • Barclays's SEQUENOM INC NEW position peaked at $352K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.

Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.